Medical Algorithms Company

www.medicalalgorithms.com/

Собраны практически все дерматологические индексы,калькуляторы и алгоритмы.При заполнении форм идет автоматический подсчет.Свободная регистрация.

Что там есть

1.  Formula of Dubois and Dubois for Body Surface Area
2.  Equations for Predicting Body Surface Area in Infants and Children
3.  Waterlow Pressure Sore Risk Scale
4.  The Glasgow 7-Point Checklist for Distinguishing a Benign Pigmented Skin Lesion from a Melanoma
5.  The Epiluminescence Microscopy (ELM) 7-Point Checklist for Evaluation of a Melanocytic Skin Lesion
6.  The ABCD Rule of Dermatoscopy (Total Dermatoscopic Score, TDS)
7.  The Score of Menzies et al for Pigmented Skin Lesions
8.  SCORAD Index Calculator | Atopic Dermatitis
9.  Criteria of Hanifin and Rajka for the Diagnosis of Atopic Dermatitis
10.  Atopic Dermatitis Therapy Score
11.  Atopic Dermatitis Area and Severity Index (ADASI) Score
12.  Grading Score of Rajka and Langeland for Severity of Atopic Dermatitis
13.  The Six Area, Six Sign Atopic Dermatitis (SASSAD) Severity Score
14.  The Atopic Dermatitis Severity Index (ADSI)
15.  Salford Psoriasis Index (SPI)
16.  Nail Psoriasis Severity Index of Baran
17.  Copenhagen Psoriasis Severity Index (CPSI)
18.  National Psoriasis Foundation Psoriasis Score (NPF-PS)
19.  Clinical Score of Layton et al for Acne Scarring
20.  Classification of Hayashi et al for Acne Severity on the Face
21.  Global Acne Grading System (GAGS)
22.  Olsen's Classification of Androgenetic Alopecia in Women (Modified Ludwig Classification with Frontal Accentuation)
23.  Severity of Alopecia Tool (SALT) Score
24.  The Ferriman-Gallwey Hirsute Score for Women
25.  Risk Score for Predicting Progression to Foot Ulceration in Diabetics
26.  Classification of Margolis et al for Diabetic Neuropathic Foot Ulcers
27.  Model of Margolis et al to Predict Healing of Diabetic Neuropathic Foot Ulcers By 20 Weeks
28.  Pima Indian Diabetic Foot Risk Classification System of Mayfield et al for Predicting Lower Extremity Diabetic Amputation
29.  Rapid Screening Foot Examination of Cavanagh et al for a Patient with Diabetes Mellitus
30.  Diabetic Ulcer Severity Score (DUSS) of Beckert et al
31.  Diabetic Foot Risk Stratification Scheme of Leese et al
32.  Model for Predicting Risk of Foot Ulceration in a Diabetic (Seattle Risk Score)
33.  Diabetic Foot Ulcer Wound Score
34.  Criteria of the National Rosacea Society Expert Committee for the Diagnosis of Rosacea
35.  Diagnostic Criteria of the Second International Hidradenitis Suppurativa (HS) Research Symposium
36.  Modified Hidradenitis Suppurativa Severity Score (HSSS) of Sartorius et al
37.  Estimating the Body Surface Area Involvement by a Skin Disorder Using the Chart of Lund and Browder
38.  Patient-Oriented Eczema Measure (POEM) of Charman et al
39.  Score of Awad et al for Evaluating a Patient with a Pilonidal Sinus
40.  Algorithm of Gibbs et al for Evaluating a Patient with Livedo Reticularis
41.  Symptom Score of Mlynek et al for a Patient with Chronic Urticaria
42.  Scoring System of Kaplan et al for Urticaria Severity
43.  Wind Chill Equation
44.  Z Score of Zawacki et al and Prognosis of Patients with Thermal Burns
45.  The DEMI Score of Demirdjian and Yunis
46.  Nomogram of Gangemi for Pathologic Scarring After a Major Burn
47.  FLAMES Score of Gomez et al for Predicting Mortality of a Burn Patient
48.  Estimating the Duration of Scalp Hair Growth in an Adult
49.  Skin Lesions That May Be Manifestation of Hepatitis C Infection
50.  Algorithm for Managing Patient with HCV-Related Cryoglobulinemia
51.  Botulinum Toxin Injections | Comorbid Conditions That May Increase Risk of Adverse Effects
52.  Criteria for Schnitzler's Syndrome
53.  Differential Diagnosis of Small Vessel Vasculitis
54.  Hidebinding/Tethering Skin Score for Scleroderma
55.  Rodnan Score for Progressive Systemic Sclerosis
56.  Modified Rodnan Skin Score in Scleroderma Using 5 Sites
57.  Organ System Indicesl in Systemic Sclerosis
58.  Kahaleh Skin Score in Scleroderma
59.  Predictors for Scleroderma Renal Crisis
60.  Scleroderma Risk Model for 5 Year Survival
61.  Criteria for Scleroderma Renal Crisis
62.  Criteria for Rapidly (Fulminant) Progressive Systemic Sclerosis
63.  Presenting Symptoms of Progressive Systemic Sclerosis
64.  Prognostic Factors for Patient with Juvenile Systemic Sclerosis
65.  Diagnostic Clues for Diagnosis of Systemic Sclerosis
66.  Drug Induced Scleroderma
67.  Lung Severity Scale of Medsger for Patient with Systemic Sclerosis
68.  Cardiac & Vascular Severity Scales for Patient with Systemic Sclerosis
69.  General & Skin Severity Scales for Patient with Systemic Sclerosis
70.  Renal & Gastrointestinal Scales for Patient with Systemic Sclerosis
71.  Joint & Muscle Scales for Patient with Systemic Sclerosis
72.  Prognostic Factors for Patient with Systemic Sclerosis
73.  Criteria for Scleroderma Renal Crisis
74.  Conditions in Differential Diagnosis of Scleroderma (Scleroderma-Like Fibrosing Skin Disorders)
75.  Prognostic Factors for Patient with Polymyositis or Dermatomyositis
76.  Overlap Syndrome in Patient with Dermatomyositis
77.  Prognostic Factors for Patient with Polymyositis or Dermatomyositis
78.  Dermatomyositis or Polymyositis | Risk Factors for Underlying Malignancy
79.  Nodules, Eosinophilia, Rheumatism, Dermatitis and Swelling (NERDS)
80.  Psoriatic Arthritis | Risk Factors for Disease Progression
81.  Psoriatic Arthritis Criteria
82.  Psoriatic Arthritis Modified Criteria for Diagnosis
83.  Criteria for Psoriatic Arthritis
84.  Psoriatic Arthritis | Classification of Disease Severity Based on Therapy & Disability
85.  Psoriatic Arthritis Response Criteria (PsARC)
86.  Contact Allergy to Polyvinylpyrrolidone, Including Povidone-Iodine
87.  Cutaneous Burns | Transdermal Patch & Defibrillation
88.  Epidermal Growth Factor Receptor (EGFR) Inhibitors | Adverse Reactions
89.  Risk of Hair Loss Associated with Chemotherapeutic Agents
90.  Psoriasis Induced By Tumor Necrosis Factor Antagonist Therapy
91.  Clinical Features of Nodular Erythema Elevatum Diutinum (NEED) in HIV Patient
92.  Appearance of Freckles or Seborrheic Keratoses and Sign of Leser-Trelat
93.  Eosinophilic Folliculitis in HIV-Infected Patient
94.  Clinical Features of Diabetic Dermopathy
95.  Clinical Features of Diabetic Bullae (Bullosis Diabeticorum)
96.  Clinical Features of Necrobiosis Lipoidica Diabeticorum
97.  Total Activity Score of Cutaneous LE Disease Area and Severity Index (CLASI)
98.  Total Damage Score | Cutaneous LE Disease Area & Severity Index (CLASI)
99.  Clinical Features of Mucosal Lupus Erythematosus
100.  Clinical Features of Chilblain Lupus Erythematosus Hutchinson
101.  Alopecia and Changes in Hair Associated with Lupus Erythematosus
102.  Use of BILAG Index to Define a Lupus Flare
103.  Mouth & Genital Ulcers with Inflamed Cartilage (MAGIC Syndrome)
104.  Behcet’s Disease | Criteria for Skin Pathergy Test (SPT)
105.  Sites of Insulin Injection (Lipoatrophy/Lipohypertrophy) | Changes in Subcutaneous Fat
106.  Site of Repeated Subcutaneous Injections | Cosmetic Skin Changes
107.  Aluminium Granulomata (Aluminum) at Injection Site
108.  Staphylococcus Furuncles Severity Grading System
109.  Pressure Ulcers Nursing Homes | Infection Criteria
110.  Clinical Signs of Invasive Infection of Burn Wound
111.  Infection of a Chronic Wound | Clinical Signs
112.  Infection of a Chronic Wound | Risk Factors
113.  CDC Criteria for Decubitus Ulcer Infection
114.  Pressure Ulcer Healing Predictors for Long Term Care Patients
115.  Cornell Ulcer Risk Score (CURS)
116.  Risk Factors for Development of Decubitus Ulcers by Surgical Patients in ICU
117.  Pressure Ulcer Risk Factors in Patients with Spinal Cord Injury
118.  Japanese Pressure Ulcer Score (OH Scale)
119.  Risk of Pressure Ulcer in Incontinent Adult
120.  Nutritional Factors Associated with Increased Risk for Pressure Ulcers
121.  Pressure-Related Intact Discolored Areas of Skin (PRIDAS)
122.  Daily Urticaria Activity Score (UAS)
123.  Urticaria Activity Score (UAS) to Measure Therapy Response
124.  Chronic Idiopathic Urticaria | Autologous Serum Skin Test (ASST)
125.  Clark Levels for Cutaneous Malignant Melanoma
126.  Therapy for Psoriasis - Factors Affecting Compliance
127.  Perceived Improved Quality of Life with Adherence to Long Term Skin Care Practices
128.  Total Active Motion (TAM) Rating Scale After Deep Dermal Burn
129.  Poinsettia Exposure
130.  Psoriasis Scalp Severity Index (PSSI)
131.  Genetic Loci Associated with Hereditary Hemorrhagic Telangiectasia (HHT)
132.  Hereditary Hemorrhagic Telangiectasia (HHT) Management
133.  Mistletoe (Phoradendron) Exposure
134.  Nutmeg Allergy
135.  Estimating Impairment Due to Skin Disorder
136.  Impairment from Skin Loss Associated with Ulcerations of Lower Extremity
137.  Functional Impairment Associated with Buruli Ulcer
138.  Occupational Hand Eczema Prognostic Factors
139.  Criteria for Disability Associated with Pruritus
140.  Photomutilation Associated with Cutaneous Porphyrias
141.  Skin Manifestations of Whipple’s Disease
142.  PASI Scoring System for Psoriasis
143.  Requirements for Diagnosing Different Patterns of Psoriasis
144.  Risk Factors for Stigma in a Patient with Psoriasis